Register an account to search through 14,000+ stocks! 

Ad

NOV – Novartis AG

Ad

✔ COMPLIANT

★★★

Pharmaceuticals | Europe

Business: PASS

Novartis AG has cleared the Business screen. Its business activity is compliant with the Shariah standard. If you find this result mistaken or questionable, let us know in the comments.

Financials: PASS

The financials pass all the three standards we check against.

FTSE

Debt/A23.54%
Cash/A6.84%
(AR+C)/A12.97%

AAOIFI

Debt/MC14.61%
Cash/MC7.4%

DJIM

Debt/24MC14.58%
Cash/24MC4.24%
AR/24MC3.8%

Total Analysts: 29

Recommendation Rating

2.5

1

2

3

4

5

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Analysts’ Price Targets

Mean 96.6

Low: 29

High: 113.6

Market cap212373893313
Assets131795000000
Dividends per Share3.4
Revenue Growth2.6

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

✔ FTSE✔ AAOIFI✔ DJIM

✔ COMPLIANT

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan.

Ad

Responses